| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/HDI.12440 |
| P698 | PubMed publication ID | 27302563 |
| P50 | author | Jin-Hee Jeong | Q86738091 |
| Annabel Guzman Biruete | Q86891722 | ||
| P2093 | author name string | Kenneth R Wilund | |
| Peter J Fitschen | |||
| P2860 | cites work | Overcoming obstacles for adherence to phosphate binding medication in dialysis patients: a qualitative study | Q46680861 |
| Walking and talking in maintenance hemodialysis patients. | Q50922593 | ||
| Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. | Q51820752 | ||
| Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. | Q51918236 | ||
| Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. | Q51931525 | ||
| Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. | Q51976856 | ||
| Falls and fall-related injuries in older dialysis patients. | Q53127701 | ||
| Falls in hemodialysis patients: prospective study of incidence, risk factors, and complications. | Q53278375 | ||
| Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. | Q53516250 | ||
| Subjective and objective physical limitations in high-functioning renal dialysis patients | Q59106168 | ||
| Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider | Q28168531 | ||
| β-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats | Q28391990 | ||
| Wasting in chronic kidney disease | Q30432774 | ||
| Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine | Q33958795 | ||
| The effect of resistance exercise to augment long-term benefits of intradialytic oral nutritional supplementation in chronic hemodialysis patients | Q34163798 | ||
| Vitamin D status affects strength gains in older adults supplemented with a combination of β-hydroxy-β-methylbutyrate, arginine, and lysine: a cohort study | Q34205375 | ||
| Development of the kidney disease quality of life (KDQOL) instrument. | Q34317595 | ||
| Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis | Q34406863 | ||
| The effect of oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine on wound healing: a retrospective analysis of diabetic haemodialysis patients | Q34545870 | ||
| Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures | Q34647810 | ||
| Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients | Q35163405 | ||
| Comparing body composition assessment tests in long-term hemodialysis patients | Q35219227 | ||
| Nutritional effect of oral supplement enriched in beta-hydroxy-beta-methylbutyrate, glutamine and arginine on resting metabolic rate after laparoscopic gastric bypass | Q35429349 | ||
| Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature | Q35959075 | ||
| Beta-hydroxy-beta-methyl-butyrate blunts negative age-related changes in body composition, functionality and myofiber dimensions in rats | Q35972756 | ||
| Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake | Q36884529 | ||
| Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients | Q37211036 | ||
| Hypercatabolism in dialysis patients | Q37305322 | ||
| Postural control in hemodialysis patients | Q37625076 | ||
| Barriers to adult hemodialysis patients' self-management of oral medications | Q37739624 | ||
| Efficacy of β-hydroxy-β-methylbutyrate supplementation in elderly and clinical populations | Q38053770 | ||
| Effect of calcium β-hydroxy-β-methylbutyrate (CaHMB) with and without resistance training in men and women 65+yrs: a randomized, double-blind pilot trial | Q38447484 | ||
| Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. | Q38467489 | ||
| Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: the Progressive Exercise for Anabolism in Kidney Disease (PEAK) study. | Q40169849 | ||
| Effects of Pomegranate Extract Supplementation on Cardiovascular Risk Factors and Physical Function in Hemodialysis Patients | Q40267799 | ||
| Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function | Q44282602 | ||
| Determinants of progressive vascular calcification in haemodialysis patients | Q44854970 | ||
| Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women | Q44856463 | ||
| Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle | Q44974719 | ||
| Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study | Q45742019 | ||
| Physical activity assessment methodology in the Five-City Project. | Q45942702 | ||
| Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), L-arginine, and L-lysine | Q46150825 | ||
| Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial | Q46492688 | ||
| P433 | issue | 1 | |
| P921 | main subject | hemodialysis patient | Q126109077 |
| P304 | page(s) | 107-116 | |
| P577 | publication date | 2016-06-14 | |
| P1433 | published in | Hemodialysis International | Q15757113 |
| P1476 | title | Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in maintenance hemodialysis patients | |
| P478 | volume | 21 |
| Q34556525 | Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions |
| Q90434069 | Intradialytic Nutrition and Hemodialysis Prescriptions: A Personalized Stepwise Approach |
| Q50059803 | Is β-hydroxy β-methylbutyrate an effective anabolic agent to improve outcome in older diseased populations? |
Search more.